Outcomes of Delivery in Patients With Dyspareunia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01753258|
Recruitment Status : Completed
First Posted : December 20, 2012
Last Update Posted : October 11, 2016
|Condition or disease|
|Dyspareunia Pregnancy Provoked Vestibulodynia Pelvic Floor Dysfunction|
|Study Type :||Observational|
|Actual Enrollment :||173 participants|
|Observational Model:||Case Control|
|Official Title:||Outcomes of Delivery in Patients With Dyspareunia- A Prospective Study|
|Study Start Date :||January 2013|
|Actual Primary Completion Date :||September 2016|
|Actual Study Completion Date :||September 2016|
Definite diagnosis of dyspareunia
Patients who report dyspareunia, and whose dyspareunia was evaluated prior to delivery by a caregiver experienced with sexual pain disorders, with definite diagnosis.
No definite diagnosis of dyspareunia
Patients who report dyspareunia but were not evaluated prior to delivery or were evaluated inappropriately (i.e. "yeast infection" without cultures, "inflammation" and other vague definitions).
Patients without dyspareunia
Patients without dyspareunia- those who report non painful sexual intercourse. This group of patients will be used as a control group.
- Obstetrical outcome of women with a history of dyspareunia [ Time Frame: 3 months -1 year ]The Investigators will record the mode of delivery (vaginal, instrumental or cesarean section), length of the second stage of labor, use of anesthetics, perineal tears and\or episiotomies, and newborn's birth weight. The evaluation will be done prospectively, comparing data with matched controls without a history of dyspareunia.
- Rate of alleviation of dyspareunia following vaginal delivery as assessed through patient questionnaires. [ Time Frame: 2 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01753258
|Hadassah Medical Organization|
|Principal Investigator:||Ahinoam Lev-Sagie, MD||Hadassah Medical Organization|